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Fig.2 Indicator results 
 
 
Conclusion: Investments in technological upgrades in public 
services can result in increased efficiency and productivity 
levels, while improving service quality, decreasing costs and 
reducing service duplication and overlapping. Our preliminary 
findings suggest the applicability of our model to the full 
cancer care pathway 
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Purpose or Objective: Information and communication 
technologies (ICTs) have enabled cost-effective eHealth 
programmes gain wider acceptance in a range of health 
disciplines. However, this is yet to be evaluated in 
radiotherapy (RT), especially in low- and middle income 
countries (LMICs). We explored the use of ICTs to create a 3-
tier network of teleradiotherapy centres (RTC), namely - 
primary (PRTC) with 1 teletherapy (TRT) unit; secondary 
(SRTC) with 2 TRT units and brachytherapy (BRT); and 
tertiary RT centre (TRTC) with state-of-the-art RT facilities. 
The cost-effectiveness of this network was evaluated for 10 
adjoining countries in middle and east Africa. 
 
Material and Methods: Seven of the 10 countries (Gabon, 
Congo Republic, Congo DR, Central African Republic, South 
Sudan, Rwanda and Burundi) have no RT facilities for their 
123.6 million inhabitants. Remaining 3 countries (Uganda, 
Kenya and Tanzania) have in total 11 TRT and 6 BRT units. 
Thus, presently, only 2.3% of 262.2 million people have RT 
access in these 10 countries. Based on the regional 
population density and location of current centres, 6 PRTCs, 
2 upgraded PRTCs (with BRT), 6 SRTCs and upgradation of an 
existing centre to SRTC are proposed. These could be 
networked to share the available resources. With DICOM RT 
compatible data sets, ICTs could facilitate an easy exchange 
of patient information between centres. Consequently, 
patients at PRTC with a standalone TRT unit could deliver RT 
based on treatment plans derived at SRTC. Similarly patients 
treated at PRTC could receive brachytherapy at SRTC. TRTC 
could cater to specialized RT techniques not feasible either 
at PRTC or SRTC. Thus, patients within the 3-tier network 
would have access to state-of-the-art technology in a shared 
step-wise manner. 
 
Results: The total cost of the infrastructure, networking, 
maintenance and incidentals is estimated around US$ 66.25 
million. With a total of 32 TRT and 15 BRT units provided in 
this network, the RT accessibility would enhance from 2.3% 
to 30.7% (9.2%-76.9%). The mean cost of this investment for 
the 262.2 million inhabitants would be around US$ 0.69 per 
inhabitant (US$ 0.12-2.22) while the average cost in terms of 
individual patients receiving RT is estimated to be US$ 374 
(US$ 71.67-508.33). Capacity building could be undertaken 
through telementoring by linking to regional or international 
centres of excellence and professional societies through 
multisectoral collaborative efforts. 
 
Conclusion: The 3 tier-teletherapy network with ICTs could 
provide cost-effective comprehensive RT care by overcoming 
the geographical barriers by optimizing resource sharing, 
pedagogical telementoring and capacity building. This could 
lead to scalable, equitable, affordable and improved RT 
access to patients of the region. The approach could be 
explored for other underserved LMICs and executed with the 
help of respective national and international stakeholders. 
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Purpose or Objective: MRI offers superior soft tissue 
delineation compared to CT. When incorporated in to a linear 
accelerator (MRI Linac), it could improve temporal resolution 
and dynamic visualisation of the target during treatment 
allowing for motion compensation and real-time adaptive 
planning. This study investigated the predicted patient 
demand for radiotherapy delivered via a MRI Linac for 
prostate and lung cancer at a large comprehensive cancer 
centre to ensure that any clinical research will be 
achievable. 
 
Material and Methods: Local stage data was sourced from 
hospital databases and the UK NHS CASCADE system. 
Indications for MRI Linac were obtained by consulting with 
the specialist clinical leads for prostate and lung cancers. 
Locally advanced patients where soft tissue definition would 
be clinically advantageous were identified (T3/4 prostate, 
stage 2/3 non-small cell lung cancer [NSCLC] including 
superior sulcus tumours and limited stage small cell lung 
cancer [SCLC] with good performance status). The Malthus 
programme was used to estimate the demand for MRI Linac. 
The Malthus programme is an evidence based, predictive 
mathematical model, based on regional population and 
incidence data, mapping around 2,000 clinical decisions 
relating to radiotherapy for 23 different cancer sites. 
 
Results: The catchment area of the comprehensive cancer 
centre in the study is approximately 3.2 million people. For 
prostate, the total projected incidence for 2015 was 1,983 
cases, of which 436 high risk patients were predicted to be 
eligible for MRI Linac. For lung, the total projected incidence 
for 2015 is 2,634 cases. Of these, a total of 360 patients were 
identified as suitable for MRI Linac (table 1). Approximately 
92 of the NSCLC’s were considered superior sulcus tumours. 
